Free Newsletter
Roche CEO frustrated by Genentech talks
Free newsletter via e-mail
Tools
In an interview with the Wall Street Journal, Roche CEO Severin Schwan reiterated his confidence that Roche will complete its acquisition of Genentech, but expressed frustration with the so-far fruitless negotiations. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: